Article
Plasma levels of interleukin 18, interleukin 10, and matrix metalloproteinase-9 and -137G/C polymorphism of interleukin 18 are associated with incidence of in-stent restenosis after percutaneous coronary intervention.
Inflammation - 1 Oct 2013
Liu Wenwei, Liu Yongsheng, Jiang Hua, Ding Xiangwu, Zhu Rui, Li Bin, Zhao Yuqin
Abstract excerpt
This study aims to investigate the relationship between the levels of IL-18, IL-10, and MMP-9 and -137G/C polymorphism of interleukin 18 with the risk of in-stent restenosis (ISR). The study population consisted of 68 patients with ISR, 173 in non-ISR group, treated with drug-eluting stent and evaluated by coronary angiography post-procedure and at follow-up, and also 109 without angiographic evidence of coronary...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
